A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Pfizer
Cancer Research UK
Novartis
Pfizer
Tango Therapeutics, Inc.
Amgen
Cancer Research UK
Ikena Oncology
Institut du Cancer de Montpellier - Val d'Aurelle